Maruti Sec. (531319)

Turnaround

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹9.75
Market Cap₹5.1 Cr
P/E Ratio0
ROCE200%
ROE-37.97%
Dividend Yield0%
Profit Growth-99.86%
Debt/Equity
Sales Growth-58.04%
52-Week Range₹26.51 — ₹78.43
SectorFinance

Strengths

Concerns

AI Analysis

At ₹9.75, Maruti Sec. is a ₹5 crore micro-cap NBFC. The first thing I notice is not cheapness; it is destruction. Sales growth is -58.04%, profit growth is -99.86%, and ROE is -37.97%. The latest quarter still records ₹6 crore of sales, but net profit rounds to ₹0 crore, so the business is barely breaking even. A Piotroski F-score of 3/9 tells me the financial health is weak. Worse, key numbers I need for an NBFC are missing: book value, debt-to-equity, promoter holding, all N/A. How can I value a lender without seeing its equity buffer or leverage? I can't. A P/E of 0.00 is meaningless because earnings have collapsed. ROCE of 200% might catch a screen, but it is misleading: return on capital employed can look inflated when the capital base is tiny, while shareholders are losing almost 38 paise per rupee of equity each year. There is no dividend. The quoted 52-week range of ₹26.51 to ₹88.02 does not even contain the current price of ₹9.75. That tells me the data may be unreliable, or the stock has suffered a catastrophic repricing. But a low price is not a margin of safety if the business itself is deteriorating. For an NBFC, asset quality and capital adequacy are the moat. Without those disclosures, this is not an investment; it is a speculation. If the company can stabilise sales, turn equity returns positive, and disclose a clean balance sheet, it might become a turnaround candidate. Until then, I must follow Graham and put it in the 'too hard' pile. In investing, you do not need to swing at every pitch. This one has a fastball of bad numbers; I will wait for a better one.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer